Advertisement
Home »

Bronchopulmonary disposition of IV cefepime/taniborbactam (2-0.5 g) administered over 2 h in healthy adult subjects.

Jan 09, 2023

ABOUT THE EXPERTS

  • Tomefa E Asempa

    Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.

    Joseph L Kuti

    Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.

    Jeffrey C Nascimento

    Division of Pulmonology, Hartford Hospital, Hartford, CT, USA.

    Samuel J Pope

    Division of Pulmonology, Hartford Hospital, Hartford, CT, USA.

    Edward L Salerno

    Division of Pulmonology, Hartford Hospital, Hartford, CT, USA.

    Patrick J Troy

    Division of Pulmonology, Hartford Hospital, Hartford, CT, USA.

    David P Nicolau

    Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.

    Division of Infectious Diseases, Hartford Hospital, Hartford, CT, USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement